VIMGF:OTC-Vimian Group AB (publ) (USD)

COMMON STOCK | Diagnostics & Research |

Last Closing

USD 2.445

Change

0.00 (0.00)%

Market Cap

USD 1.34B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-05 )

Largest Industry Peers for Diagnostics & Research

Symbol Name Price(Change) Market Cap
LZAGF Lonza Group Ltd

N/A

USD 41.97B
LZAGY Lonza Group AG

N/A

USD 41.89B
WUXIF WuXi AppTec Co. Ltd

N/A

USD 17.70B
BMXMF bioMérieux S.A

N/A

USD 12.65B
ERFSF Eurofins Scientific SE

N/A

USD 12.53B
SKHCF Sonic Healthcare Limited

N/A

USD 8.77B
SKHHY Sonic Healthcare Ltd ADR

N/A

USD 8.63B
HNGZY Hangzhou Tigermed Consulting C..

N/A

USD 5.92B
DSRLF DiaSorin S.p.A

N/A

USD 5.73B
MRCHF H.U. Group Holdings Inc

N/A

USD 0.82B

ETFs Containing VIMGF

N/A

Market Performance

  Market Performance vs. Industry/Classification (Diagnostics & Research) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 8.67% 68% D+ 66% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.67% 68% D+ 65% D
Trailing 12 Months  
Capital Gain -36.49% 49% F 31% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -36.49% 49% F 30% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -8.86% 21% F 24% F
Dividend Return -8.86% 21% F 22% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.45% 100% F 95% A
Risk Adjusted Return -71.21% 10% F 10% F
Market Capitalization 1.34B 86% B+ 72% C

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.